{"id":"placebo-toxin","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4176158","moleculeType":"Small molecule","molecularWeight":"320.34"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo, this agent contains no active pharmaceutical ingredient and serves as a control arm in clinical studies. It is used to measure the placebo effect and distinguish true drug efficacy from psychological or natural disease progression effects. The term 'toxin' in the name is unusual and may reflect historical nomenclature or a specific formulation context at the institution.","oneSentence":"Placebo toxin is a non-active control substance used in clinical trials to establish baseline efficacy and safety comparisons.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:01:29.591Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT02392442","phase":"PHASE2","title":"Effects of Bronchial Segmental Endotoxin Instillation in Humans","status":"ENROLLING_BY_INVITATION","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2015-06-18","conditions":"Acute Lung Inflammation","enrollment":58},{"nctId":"NCT06665074","phase":"PHASE2","title":"Inflammatory Challenge in Human Aggression.","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2026-02-16","conditions":"Intermittent Explosive Disorder","enrollment":112},{"nctId":"NCT05610800","phase":"PHASE2","title":"Exenatide for Smoking Cessation and Prevention of Weight Gain","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-12-07","conditions":"Smoking Cessation, Weight Gain","enrollment":140},{"nctId":"NCT07486830","phase":"PHASE2","title":"IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction","status":"RECRUITING","sponsor":"Center for Vulvovaginal Disorders","startDate":"2026-02-27","conditions":"Provoked Vestibulodynia","enrollment":54},{"nctId":"NCT07018700","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine","status":"RECRUITING","sponsor":"Merz Therapeutics GmbH","startDate":"2025-08-21","conditions":"Episodic Migraine","enrollment":990},{"nctId":"NCT07018713","phase":"PHASE3","title":"A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine","status":"RECRUITING","sponsor":"Merz Therapeutics GmbH","startDate":"2025-08-21","conditions":"Chronic Migraine","enrollment":780},{"nctId":"NCT03992404","phase":"PHASE3","title":"Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merz Pharmaceuticals GmbH","startDate":"2019-09-16","conditions":"Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury","enrollment":603},{"nctId":"NCT07426640","phase":"NA","title":"Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation","status":"COMPLETED","sponsor":"Al Mouwasat Hospital","startDate":"2021-11-01","conditions":"Premature (Early) Ejaculation","enrollment":150},{"nctId":"NCT06692907","phase":"PHASE2","title":"Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-03-31","conditions":"Escherichia Infection","enrollment":72},{"nctId":"NCT06252623","phase":"PHASE1","title":"Exenatide For Reducing the Reinforcing Effects of Cocaine","status":"WITHDRAWN","sponsor":"Christopher D. Verrico","startDate":"2024-08-01","conditions":"Cocaine Use Disorder","enrollment":""},{"nctId":"NCT07452146","phase":"PHASE2","title":"Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-06","conditions":"Alcohol Use Disorder, Inflammatory Response, Craving","enrollment":64},{"nctId":"NCT07399860","phase":"PHASE2","title":"Botulinum Toxin A Before Hemorrhoidectomy to Prevent Postoperative Pain","status":"RECRUITING","sponsor":"Lomonosov Moscow State University Medical Research and Educational Center","startDate":"2026-02-01","conditions":"Hemorrhoids, Postoperative Pain","enrollment":292},{"nctId":"NCT07140874","phase":"PHASE2","title":"Zinc as an Adjunctive Therapy for Cervical Dystonia","status":"RECRUITING","sponsor":"University of Florida","startDate":"2026-02-20","conditions":"Cervical Dystonia","enrollment":20},{"nctId":"NCT07405554","phase":"PHASE2","title":"Zinc Supplementation With Botulinum Toxin for Overactive Bladder","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2026-02-26","conditions":"Overactive Bladder (OAB)","enrollment":72},{"nctId":"NCT06047457","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ipsen","startDate":"2023-09-29","conditions":"Episodic Migraine","enrollment":751},{"nctId":"NCT06047444","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ipsen","startDate":"2023-10-12","conditions":"Chronic Migraine","enrollment":759},{"nctId":"NCT02251431","phase":"PHASE3","title":"Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome","status":"COMPLETED","sponsor":"Baylor Research Institute","startDate":"2015-11","conditions":"Type 2 Diabetes Mellitus, Chronic Kidney Disease, Left Ventricular Diastolic Dysfunction","enrollment":57},{"nctId":"NCT05248880","phase":"PHASE3","title":"A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines","status":"COMPLETED","sponsor":"AbbVie","startDate":"2022-03-08","conditions":"Glabellar Lines","enrollment":309},{"nctId":"NCT06995287","phase":"PHASE3","title":"Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2026-02-09","conditions":"Primary Dysmenorrhea, Chronic Pelvic Pain","enrollment":222},{"nctId":"NCT05650645","phase":"PHASE2","title":"The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2023-01-01","conditions":"Tinnitus","enrollment":41},{"nctId":"NCT05330182","phase":"PHASE2, PHASE3","title":"LMN-201 for Prevention of C. Difficile Infection Recurrence","status":"RECRUITING","sponsor":"Lumen Bioscience, Inc.","startDate":"2024-08-29","conditions":"Clostridioides Difficile Infection","enrollment":375},{"nctId":"NCT07387315","phase":"PHASE4","title":"A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections","status":"NOT_YET_RECRUITING","sponsor":"TriHealth Inc.","startDate":"2026-02","conditions":"Overactive Bladder, Neurogenic Bladder, Urge Incontinence","enrollment":96},{"nctId":"NCT07149454","phase":"PHASE1","title":"Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection","status":"ENROLLING_BY_INVITATION","sponsor":"Lanzhou Institute of Biological Products Co., Ltd","startDate":"2025-08-18","conditions":"Tetanus","enrollment":68},{"nctId":"NCT07374510","phase":"PHASE1","title":"Phase Ia Clinical Trial of Group ACYW135X Meningococcal Conjugate Vaccine","status":"NOT_YET_RECRUITING","sponsor":"Sinovac Life Sciences Co., Ltd.","startDate":"2026-01-21","conditions":"Meningococcal Meningitis","enrollment":150},{"nctId":"NCT03848715","phase":"PHASE1","title":"Sleep and Healthy Aging Research on Depression for Younger Women","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2019-10-02","conditions":"Anhedonia, Depression","enrollment":40},{"nctId":"NCT05987488","phase":"PHASE1","title":"ShigETEC Vaccine Study in Bangladesh","status":"COMPLETED","sponsor":"Eveliqure Biotechnologies GmbH","startDate":"2023-11-26","conditions":"Healthy Volunteers","enrollment":196},{"nctId":"NCT06783114","phase":"PHASE2, PHASE3","title":"A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults","status":"RECRUITING","sponsor":"Chongqing Claruvis Pharmaceutical Co., Ltd.","startDate":"2024-09-14","conditions":"Upper Limb Spasticity","enrollment":254},{"nctId":"NCT02414425","phase":"PHASE3","title":"Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2015-11-25","conditions":"Fecal Incontinence","enrollment":200},{"nctId":"NCT04897802","phase":"PHASE4","title":"Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2021-09-13","conditions":"Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism","enrollment":42},{"nctId":"NCT05216250","phase":"PHASE2","title":"Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor","status":"COMPLETED","sponsor":"AbbVie","startDate":"2022-04-12","conditions":"Upper Limb Essential Tremor (UL ET)","enrollment":174},{"nctId":"NCT05478551","phase":"PHASE2, PHASE3","title":"Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization","status":"ACTIVE_NOT_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2022-06-01","conditions":"Scar, Hypertrophic Scar","enrollment":12},{"nctId":"NCT06389474","phase":"PHASE3","title":"Efficacy of INM004 in Children With STEC-HUS","status":"RECRUITING","sponsor":"Inmunova S.A.","startDate":"2024-10-05","conditions":"Hemolytic-Uremic Syndrome","enrollment":220},{"nctId":"NCT02586831","phase":"PHASE1, PHASE2","title":"Diabetes Islet Preservation Immune Treatment","status":"WITHDRAWN","sponsor":"Camillo Ricordi and Jay Skyler","startDate":"2024-06-01","conditions":"Diabetes Mellitus, Type 1, Hypoglycemia, Autoimmune Diseases","enrollment":""},{"nctId":"NCT04520490","phase":"PHASE3","title":"Brain Activation and Satiety in Children 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seattle Children's Hospital","startDate":"2021-01-28","conditions":"Childhood Obesity","enrollment":63},{"nctId":"NCT06237465","phase":"PHASE4","title":"Botulinum Toxin-A for Hidradenitis Suppurativa","status":"WITHDRAWN","sponsor":"Yale University","startDate":"2025-01","conditions":"Hidradenitis Suppurativa, Hidradenitis Suppurativa \\(HS\\), Hidradenitis Suppurativa, Acne Inversa","enrollment":""},{"nctId":"NCT06387394","phase":"PHASE3","title":"A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence","status":"COMPLETED","sponsor":"AbbVie","startDate":"2024-04-22","conditions":"Masseter Muscle Prominence","enrollment":202},{"nctId":"NCT05363527","phase":"PHASE1","title":"Aging and Reward System Response to Inflammation and Anxiety Study","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2023-03-29","conditions":"Anhedonia, Inflammation, Anxiety","enrollment":40},{"nctId":"NCT06068855","phase":"PHASE3","title":"A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult Participants","status":"COMPLETED","sponsor":"AbbVie","startDate":"2023-10-17","conditions":"Masseter Muscle Prominence","enrollment":249},{"nctId":"NCT03935295","phase":"PHASE4","title":"Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2020-09-03","conditions":"Adolescent Idiopathic Scoliosis","enrollment":90},{"nctId":"NCT05028569","phase":"PHASE3","title":"Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine","status":"TERMINATED","sponsor":"AbbVie","startDate":"2021-11-05","conditions":"Episodic Migraine","enrollment":775},{"nctId":"NCT03829475","phase":"PHASE2","title":"ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-01-01","conditions":"Inflammatory Bowel Diseases, Clostridium Difficile Infection","enrollment":61},{"nctId":"NCT07270042","phase":"NA","title":"Evaluation the Efficacy of Zinc on Botulinum Toxin A Injection","status":"NOT_YET_RECRUITING","sponsor":"Tishreen University","startDate":"2025-12-01","conditions":"Hyperactive Masseter Muscle","enrollment":20},{"nctId":"NCT06356025","phase":"PHASE4","title":"Botulinum Toxin Injection in the UES for R-CPD","status":"ACTIVE_NOT_RECRUITING","sponsor":"AZ Delta","startDate":"2024-09-02","conditions":"Retrograde Cricopharyngeus Dysfunction","enrollment":50},{"nctId":"NCT05008731","phase":"PHASE3","title":"Cyclops Syndrome After Anterior Cruciate Ligament Reconstruction","status":"ACTIVE_NOT_RECRUITING","sponsor":"GCS Ramsay Santé pour l'Enseignement et la Recherche","startDate":"2024-07-18","conditions":"Hamstring Contractures","enrollment":132},{"nctId":"NCT04829565","phase":"PHASE4","title":"Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2021-09-09","conditions":"Rhizarthrosis","enrollment":60},{"nctId":"NCT07242300","phase":"PHASE3","title":"Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .","status":"NOT_YET_RECRUITING","sponsor":"JHM BioPharma (Tonghua) Co. , Ltd.","startDate":"2026-01","conditions":"Upper Limb Spasticity (ULS)","enrollment":207},{"nctId":"NCT07220382","phase":"PHASE4","title":"Preoperative BOTOX® Injection for Large Ventral Hernia Repair","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-11-03","conditions":"Hernia Abdominal Wall, Botox Injection, Hernia Incisional Ventral","enrollment":188},{"nctId":"NCT06399718","phase":"PHASE3","title":"A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants","status":"COMPLETED","sponsor":"AbbVie","startDate":"2024-04-30","conditions":"Masseter Muscle Prominence","enrollment":207},{"nctId":"NCT06834789","phase":"PHASE1","title":"A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)","status":"COMPLETED","sponsor":"AbbVie","startDate":"2025-02-18","conditions":"Glabellar Lines","enrollment":132},{"nctId":"NCT05330078","phase":"EARLY_PHASE1","title":"Examining the Therapeutic Potential of Botulinum Toxin Type A in the Treatment of Keloids","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2022-03-11","conditions":"Keloid","enrollment":10},{"nctId":"NCT04527185","phase":"PHASE2","title":"Effect of Endotoxin on Alcohol Consumption","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-02-27","conditions":"Alcohol Use Disorder","enrollment":27},{"nctId":"NCT06604832","phase":"PHASE1","title":"Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture","status":"COMPLETED","sponsor":"Kalpna Kay Durairaj, MD, FACS","startDate":"2024-09-03","conditions":"Skin Aging, Skin Wrinkling","enrollment":20},{"nctId":"NCT06937944","phase":"PHASE3","title":"Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines","status":"RECRUITING","sponsor":"JHM BioPharma (Tonghua) Co. , Ltd.","startDate":"2025-04-30","conditions":"Moderate to Severe Glabellar Lines","enrollment":669},{"nctId":"NCT06584240","phase":"PHASE1, PHASE2","title":"A Clinical Study to Evaluate the Safety and Efficacy of JHM03 in Adult Patients With Upper Limb Spasticity","status":"COMPLETED","sponsor":"JHM BioPharma (Tonghua) Co. , Ltd.","startDate":"2024-09-14","conditions":"Upper Limb Spasticity","enrollment":84},{"nctId":"NCT06246552","phase":"PHASE2","title":"Clinical Trial to Evaluate the Safety and Efficacy of JTM201 to Treat Moderate or Severe Glabellar Lines","status":"COMPLETED","sponsor":"Jetema USA Inc.","startDate":"2024-10-26","conditions":"Glabellar Lines","enrollment":480},{"nctId":"NCT06174688","phase":"PHASE3","title":"A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult Participants","status":"COMPLETED","sponsor":"AbbVie","startDate":"2023-12-12","conditions":"Forehead Lines","enrollment":140},{"nctId":"NCT06137287","phase":"PHASE3","title":"A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants","status":"COMPLETED","sponsor":"AbbVie","startDate":"2023-11-22","conditions":"Masseter Muscle Prominence","enrollment":259},{"nctId":"NCT06794866","phase":"PHASE3","title":"A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2025-01-22","conditions":"Forehead Lines","enrollment":150},{"nctId":"NCT06771323","phase":"PHASE2","title":"Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia","status":"RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2024-12-17","conditions":"Cervical Dystonia","enrollment":20},{"nctId":"NCT04069897","phase":"PHASE3","title":"Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Olavs Hospital","startDate":"2019-10-01","conditions":"Migraine Disorders","enrollment":170},{"nctId":"NCT07092215","phase":"EARLY_PHASE1","title":"Mechanisms of Pain Hypersensitivity in a Human Skin Inflammation Model","status":"COMPLETED","sponsor":"Stefan Heber","startDate":"2025-06-17","conditions":"Pain","enrollment":42},{"nctId":"NCT06091020","phase":"PHASE2","title":"A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury","status":"COMPLETED","sponsor":"Merz Therapeutics GmbH","startDate":"2023-11-22","conditions":"Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury","enrollment":123},{"nctId":"NCT04398719","phase":"EARLY_PHASE1","title":"CBD-Microglia PET Study","status":"RECRUITING","sponsor":"Yale University","startDate":"2021-05-07","conditions":"CBD, Healthy","enrollment":15},{"nctId":"NCT07070817","phase":"NA","title":"A Clinical Study of Ultrasound-guided Botulinum Toxin A Into Salivary Gland for Sialorrhea After True Bulbar Palsy","status":"ENROLLING_BY_INVITATION","sponsor":"houyajing","startDate":"2024-06-01","conditions":"Sialorrhea True Bulbar Palsy Medullary Injury","enrollment":70},{"nctId":"NCT03142919","phase":"PHASE1","title":"Lipopolysaccharide (LPS) Challenge in Depression","status":"COMPLETED","sponsor":"Laureate Institute for Brain Research, Inc.","startDate":"2017-09-07","conditions":"Major Depressive Disorder","enrollment":64},{"nctId":"NCT07040813","phase":"PHASE3","title":"The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2025-06-06","conditions":"Migraine, Chronic Migraine Headache","enrollment":450},{"nctId":"NCT05327972","phase":"PHASE2","title":"DEgenerative ROtator Cuff Disease and Botulinum TOXin","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-01-20","conditions":"Degenerative Rotator Cuff Disease","enrollment":60},{"nctId":"NCT03887377","phase":"PHASE2, PHASE3","title":"The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2019-06-10","conditions":"Scar, Hypertrophic Scar, Mammary Disorder","enrollment":22},{"nctId":"NCT07013240","phase":"PHASE3","title":"Botulinum Toxin Injection After Sternotomies to Improve Scar Aspect and Impact","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2025-07-05","conditions":"Sternotomy Closure,Open Heart Surgery","enrollment":50},{"nctId":"NCT03985982","phase":"PHASE3","title":"Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)","status":"COMPLETED","sponsor":"Croma-Pharma GmbH","startDate":"2019-04-29","conditions":"Glabellar Frown Lines","enrollment":410},{"nctId":"NCT03548064","phase":"PHASE1","title":"A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-03-10","conditions":"Gastroenteritis Escherichia Coli, Immunisation","enrollment":75},{"nctId":"NCT06863194","phase":"PHASE1, PHASE2","title":"Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2025-04-03","conditions":"Kidney Disease, Chronic, Renal Insufficiency, Chronic, Gut Dysbiosis","enrollment":72},{"nctId":"NCT04075981","phase":"PHASE3","title":"Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-09-30","conditions":"Cardiac Surgery","enrollment":220},{"nctId":"NCT04073303","phase":"PHASE3","title":"BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle Prominence","status":"COMPLETED","sponsor":"AbbVie","startDate":"2019-08-29","conditions":"Masseter Muscle Prominence","enrollment":377},{"nctId":"NCT05141006","phase":"PHASE2","title":"Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)","status":"COMPLETED","sponsor":"AbbVie","startDate":"2022-03-29","conditions":"Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)","enrollment":83},{"nctId":"NCT04310423","phase":"PHASE2","title":"An Inflammatory Challenge Using Endotoxin","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2021-10-19","conditions":"Alcohol Use Disorder, Inflammatory Response, Craving","enrollment":20},{"nctId":"NCT06319898","phase":"NA","title":"Relaxing Environment to Lower Anxiety During Onabotulinum Toxin Chemodenervation of the Bladder","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2024-05-22","conditions":"Anxiety, Pain, Burnout, Professional","enrollment":113},{"nctId":"NCT06902805","phase":"PHASE2, PHASE3","title":"Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis.","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-05","conditions":"Base-of-thumb Osteoarthritis, Osteoarthritis","enrollment":120},{"nctId":"NCT06624436","phase":"PHASE4","title":"Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2024-10-24","conditions":"Sepsis, Neuroinflammatory Response, Immunosuppresion","enrollment":52},{"nctId":"NCT06199336","phase":"PHASE1, PHASE2","title":"A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"JHM BioPharma (Tonghua) Co. , Ltd.","startDate":"2024-01-19","conditions":"Moderate to Severe Glabellar Lines","enrollment":190},{"nctId":"NCT04826094","phase":"PHASE1","title":"A Study to Assess the Safety and Immune Response to Env-C DNA and Protein Vaccines in Kenya","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-03-15","conditions":"HIV Infections","enrollment":143},{"nctId":"NCT05331885","phase":"PHASE3","title":"A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2","status":"TERMINATED","sponsor":"Aridis Pharmaceuticals, Inc.","startDate":"2022-09-02","conditions":"Ventilator Associated Pneumonia, Staphylococcus Aureus","enrollment":24},{"nctId":"NCT02677805","phase":"PHASE3","title":"Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II","status":"COMPLETED","sponsor":"Croma-Pharma GmbH","startDate":"2016-03-30","conditions":"Glabellar Frown Lines","enrollment":251},{"nctId":"NCT02677298","phase":"PHASE3","title":"Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I","status":"COMPLETED","sponsor":"Croma-Pharma GmbH","startDate":"2016-03-02","conditions":"Glabellar Frown Lines","enrollment":784},{"nctId":"NCT04857671","phase":"PHASE3","title":"Botulinum Toxin A in Frequent and Chronic Tension-type Headache","status":"COMPLETED","sponsor":"Helse Nord-Trøndelag HF","startDate":"2022-10-03","conditions":"Tension-Type Headache","enrollment":66},{"nctId":"NCT06814535","phase":"PHASE2, PHASE3","title":"A Comparative Study on the Impact of Trigger Points Injection of Platelet Rich Plasma Versus Botulinum Toxin on the Relief of Jaw Muscles Myofascial Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-06-01","conditions":"Patients with Jaw Muscles Myofascial Pain","enrollment":60},{"nctId":"NCT06839118","phase":"PHASE3","title":"Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache","status":"RECRUITING","sponsor":"Danish Headache Center","startDate":"2025-01-10","conditions":"Posttraumatic Headache","enrollment":80},{"nctId":"NCT05359133","phase":"PHASE2","title":"A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain","status":"TERMINATED","sponsor":"Wex Pharmaceuticals Inc.","startDate":"2022-04-19","conditions":"Chemotherapy-induced Neuropathic Pain, Chemotherapy-induced Peripheral Neuropathy","enrollment":35},{"nctId":"NCT05125029","phase":"PHASE4","title":"Botulinum Toxin in Raynaud's Phenomenon","status":"RECRUITING","sponsor":"Emory University","startDate":"2022-02-10","conditions":"Raynaud Phenomenon","enrollment":36},{"nctId":"NCT06778421","phase":"PHASE1","title":"Impact of OnabotulinumtoxinA (BOTOX®) on Stress","status":"RECRUITING","sponsor":"Center for Advanced Facial Plastic Surgery","startDate":"2025-01-20","conditions":"Stress (Psychology), Stress, Healthy Adult Female Participants","enrollment":20},{"nctId":"NCT06793683","phase":"EARLY_PHASE1","title":"Early BOTOX After Spinal Cord Injury","status":"ENROLLING_BY_INVITATION","sponsor":"University of Washington","startDate":"2024-07-27","conditions":"Spinal Cord Injuries","enrollment":10},{"nctId":"NCT06499324","phase":"PHASE3","title":"Surgery with Botulinum Toxin a for Incisional Hernia","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-01-17","conditions":"Incisional Hernia","enrollment":260},{"nctId":"NCT06762509","phase":"","title":"The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine","startDate":"2016-12-01","conditions":"Wilson Disease","enrollment":60},{"nctId":"NCT02196155","phase":"NA","title":"Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2016-07","conditions":"Plantar Fasciitis","enrollment":54},{"nctId":"NCT04949399","phase":"PHASE3","title":"A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence","status":"COMPLETED","sponsor":"AbbVie","startDate":"2021-07-08","conditions":"Platysma Prominence","enrollment":408},{"nctId":"NCT03944876","phase":"PHASE3","title":"Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache","status":"RECRUITING","sponsor":"Norwegian University of Science and Technology","startDate":"2019-11-01","conditions":"Cluster Headache","enrollment":112},{"nctId":"NCT06676475","phase":"PHASE2, PHASE3","title":"Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle","status":"NOT_YET_RECRUITING","sponsor":"Misr University for Science and Technology","startDate":"2024-12-01","conditions":"Myofacial Pain, Trigger Points, Myofascial","enrollment":60},{"nctId":"NCT05961059","phase":"PHASE1","title":"InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2024-10-10","conditions":"Shigellosis, Bacillary Dysentery","enrollment":85},{"nctId":"NCT05146999","phase":"PHASE3","title":"Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2022-05-09","conditions":"Glabellar Frown Lines","enrollment":132},{"nctId":"NCT04171115","phase":"PHASE1","title":"Study to Evaluate Safety and PK of a Single IM Dose of G03-52-01 vs Placebo in Adult Subjects","status":"COMPLETED","sponsor":"Alachua Government Services, Inc.","startDate":"2020-06-01","conditions":"Healthy","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1623,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["placebo injection"],"phase":"marketed","status":"active","brandName":"Placebo toxin","genericName":"Placebo toxin","companyName":"University Hospital, Toulouse","companyId":"university-hospital-toulouse","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo toxin is a type of intervention used in clinical trials to compare the effects of a real treatment, such as onabotulinumtoxinA, in studies for conditions like temporomandibular joint disorders and cerebral palsy. The placebo toxin is used as a control group in these studies to determine the efficacy of the actual treatment being tested.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":4,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}